×
Hero Background

Anti Radiation Drugs Companies

ID: MRFR/Pharma/10741-HCR
130 Pages
Rahul Gotadki
October 2025

Anti-radiation drugs, also known as radioprotective agents, are medications designed to protect cells and tissues from the harmful effects of ionizing radiation. These drugs may be used in situations where individuals are exposed to high levels of radiation, such as during certain medical treatments, nuclear accidents, or radiation therapy.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Anti Radiation Drugs Market Research Report 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Anti Radiation Drugs Market

Anti-Radiation Drugs Key Companies

 


Latest Anti-Radiation Drugs Companies Update:

Amgen Nplate remains the only FDA-approved drug for ARS treatment, positioning Amgen as a key player in the market. The recent US government purchase further strengthens their position.


Anbex The company is developing HEMATO-STEM, a potential candidate for ARS treatment in late-stage clinical trials. Positive results could significantly impact the market landscape.


Chrysalis BioTherapeutics Acquired the exclusive US rights to PLG02, another late-stage ARS treatment candidate, potentially entering the market soon.


List of Anti-Radiation Drugs Key companies in the market

  • Amgen Inc.

  • Anbex Inc.

  • Arco Pharmaceuticals LLC

  • BTG International Inc.

  • Cellphire, Inc.

  • Chrysalis BioTherapeutics, Inc.

  • Darnitsa

  • Enzychem Lifesciences Corporation

  • Humanetics Corporation

  • Mission Pharmacal Company

  • Myelo Therapeutics GmbH

  • Partner Therapeutics

  • Pluri Inc.